Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Jan 28 2021

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jan-28-2021-16

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 28, 2021, titled "Glenmark Pharmaceuticals receives ANDA approval for Amphetamine Sulfate Tablets USP, 5 mg and 10 mg".

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases